All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

It has been widely accepted that surgical site infections (SSIs) are an important component of all the nosocomial infection. Three types of SSIs are defined by the Centers for Disease Control and Prevention (CDC), including superficial, deep incisional SSIs and organ-space SSIs, depending on the sites and the extent of infection \[[@pone.0116079.ref001]\], among which superficial incisional SSIs are more common than the other two types \[[@pone.0116079.ref002]\]. In the United States (US) 2%--5% of patients undergoing surgeries develop SSIs of varying severity \[[@pone.0116079.ref003]\]. In studies from Europe, SSIs have a similar incidence, hovering at 3%--5% among patients undergoing surgery \[[@pone.0116079.ref004], [@pone.0116079.ref005]\]. SSIs are associated with increased morbidity and mortality rate \[[@pone.0116079.ref006]\]. In addition, patients with SSIs have a heavy economic burden in terms of extended length of stay and increased costs of treatment \[[@pone.0116079.ref007]\].

Various pathogens can contribute to SSIs, but significant concern has been raised for *Staphylococcus aureus* (*S. aureus*) and methicillin-resistant *Staphylococcus aureus* (MRSA). As the primary pathogen, *S. aureus* constitute approximately 20% of SSIs cases among hospitals according to the CDC \[[@pone.0116079.ref008]\]. From 1992 to 2002 the proportion of SSIs caused by *S. aureus* increased from 16.6% to 30.9%, during which time MRSA isolates increased from 9.2% to 49.3% \[[@pone.0116079.ref009]\]. The 90 days post-operative mortality was 6.7% and 20.7% for SSIs patients with methicillin-susceptible *S. aureus* (MSSA) and MRSA, respectively \[[@pone.0116079.ref010]\]. Compared with MSSA, the additional hospital charge associated with MRSA was at least \$40,000 \[[@pone.0116079.ref010]\].

In China, the proportions of *S. aureus* in SSIs have been available from the Nosocomial Infection Surveillance System since 1990s; however, the system which covers a wide range of nosocomial infections is not specific to SSIs and the statistics reported from the system to date remain far from sufficient to describe the epidemiology of *S. aureus* or MRSA in SSIs across the country. Up to now, only three studies \[[@pone.0116079.ref011]--[@pone.0116079.ref013]\] have been published on the basis of this system, reporting the proportion of *S. aureus* in SSIs. According to the data from 79 hospitals in the system *S. aureus* accounted for 12.7% (377/2,971) between 1999 and 2001 \[[@pone.0116079.ref011]\] and 13.5% (515/3812) between 1999 and 2005 \[[@pone.0116079.ref012]\] among pathogens in SSIs. The proportions of *S. aureus* in patients with superficial incisional, deep incisional and organ-space infections were 14.1%, 12.8% and 7.4% respectively between 1999 and 2007 based on the data from 110 hospitals \[[@pone.0116079.ref013]\]. Furthermore, several limitations of the publications from this system existed. Firstly, the selected hospitals in the studies seemed unable to represent all the nationwide hospitals. The number of hospitals within the system had amounted to 134 in 2001 \[[@pone.0116079.ref014]\], but none of the studies involved all or a random sample of the hospitals to estimate the proportion of *S. aureus* in SSIs patients, which may introduce selection bias. Secondly, the exact data about the proportions of MRSA and the proportions of drug resistance of MRSA in SSIs, which should be the main concern from the perspective of clinical practice, are not accessible in the studies. In addition, this system only provided the overall proportion of *S. aureus* rather than proportions by year, region, hospital level, and surgery type, which are likely to have more significant impact on decision-making for clinical practice and public health.

Understanding the nationwide epidemiological situation of *S. aureus* and MRSA in SSIs is vital for policy makers and clinicians to develop appropriate preventive countermeasures. As the national data in China remain inadequate, this systematic review aimed to estimate the proportions of *S. aureus* and MRSA in SSIs, by summarizing and assessing the available observational studies in China published from 2007 to 2012, to provide further evidence.

Methods {#sec002}
=======

Information sources and search strategy {#sec002a}
---------------------------------------

We performed systematic search in six electronic databases, including PubMed, Embase (OVID), Chinese BioMedical Database (CBM), China National Knowledge Infrastructure (CNKI), VIP Chinese Science and Technique Journals Database, and Wanfang Database, to identify the relevant studies. Since the focus in the review was on the epidemiological characteristics of *S. aureus* and MRSA in SSIs during recent years, search was limited to the publication date from January 2007 to November 2012. A combination of Mesh words and free text words applied to PubMed, Embase and CBM, and free text words were used to search CNKI, VIP and Wanfang database. The following search terms were mainly used: "surgery", "wound infection\*", "postoperative wound infection\*", "surgical site infection\*", "*S. aureus*.", "*Staphylococcus aureus*", "methicillin", "MSSA" and "MRSA". Details of the search strategies for each database were summarized in [S1 Table](#pone.0116079.s004){ref-type="supplementary-material"}.

Eligibility criteria {#sec002b}
--------------------

Criteria of inclusion:

-   Patients: those with SSIs regardless of other characteristics;

-   Outcomes: *S. aureus* and MRSA isolates identified from SSIs;

-   Study types: observational studies including cross-sectional, monitoring, prospective, ambispective and retrospective study.

Criteria of exclusion:

-   Duplicate studies;

-   Involvement of studied population from outside mainland China;

-   Therapeutic study including randomized controlled trial and observational research for comparative effectiveness;

-   Studies with data from the China Nosocomial Infection Surveillance System.

Study selection {#sec002c}
---------------

According to the criteria of inclusion and exclusion, two reviewers independently screened each record by the title, keywords and abstract. The eligibility was determined further through the full texts if selection cannot be made only based on the screening. Any disagreement was resolved by the third reviewer.

Data extraction {#sec002d}
---------------

An original extraction form was designed and then modified following a pilot test. The revised extraction form encompassed three parts: general information, clinical characteristics and numbers for calculating proportions of *S. aureus* and MRSA isolates. Two reviewers extracted information from each study independently. Any disagreement was also resolved by the third reviewer.

Assessment of risk of bias {#sec002e}
--------------------------

As there were no acknowledged or standardized quality assessment tools for the included study designs, we used a checklist with 8 items adapted from a scale for case series \[[@pone.0116079.ref015]\], which was originally developed by the National Institute for Health and Care Excellence (NICE), a special health authority in the UK which is committed to providing national guidance and advice to improve health and social care. Low, high or unclear risk of bias for each item was determined according to the pre-specified criteria ([S2 Table](#pone.0116079.s005){ref-type="supplementary-material"}) and the graph of summary of risk of bias was developed with Revman 5.1. One point was scored if an item was judged low risk of bias. We defined study of higher quality with a total of at least 4 points.

Dealing with missing data {#sec002f}
-------------------------

When information of the variables for analysis was missing from publications, the correspondent authors were contacted by email every one week. If the authors did not reply to the emails after our second contact attempt, the publications were excluded when the related variables were analyzed.

Statistical analysis {#sec002g}
--------------------

We conducted all the data analyses using R (Version 3.1.2, The R Foundation for Statistical Computing).

Calculation formula for the proportions of *S. aureus* and MRSA {#sec002h}
---------------------------------------------------------------

Proportions of *S. aureus* and MRSA isolates were calculated by the following formula for each related study: $$\text{Proportion\ of\ S.\ aureus} = \frac{\text{Number\ of\ S.\ aureus\ isolates\ detected}}{\text{Number\ of\ all\ the\ detected\ isolates}} \times 100\%$$ $$\text{Proportion\ of\ MRSA} = \frac{\text{Number\ of\ MRSA\ isolates\ detected}}{\text{Number\ of\ S.aureus\ isolates\ detected}} \times 100\%$$ $$\text{Proportion\ of\ antibiotics-resistant\ MRSA} = \frac{\text{Number\ of\ detected\ MRSA\ isolates\ resistant\ to\ a\ given\ antibiotic}}{\text{Number\ of\ MRSA\ isolates\ detected}} \times 100\%$$ Incremental 0.5 was added to both the numerator and denominator in studies with zero or all events. 95% CI for the proportion in each study was calculated based on the logit-transformed metric.

Pooled overall proportions {#sec002i}
--------------------------

Meta-analysis was conducted for the pooled estimates, followed by comparison between our overall estimate of *S. aureus* and MRSA and the corresponding proportions in the US and in the China Nosocomial Infection Surveillance System. Statistical difference between the proportions in such comparisons was tested by Q statistic for heterogeneity \[[@pone.0116079.ref016]\]. P-value of less than 0.05 indicated statistical significance. Considering probable heterogeneity across all the observational studies, random-effects model with Der-Simonian Laird method was used *a priori* throughout the data analyses.

Heterogeneity and subgroup analysis {#sec002j}
-----------------------------------

Q test and I^2^ statistic were used to examine and quantify the heterogeneity of the logit-transformed proportion across the studies. P-value of less than 0.05 or I^2^ statistic of more than 50% were regarded as substantial heterogeneity \[[@pone.0116079.ref017]\]. Subgroup analysis was conducted to explore the possible sources of heterogeneity based on the pre-defined variables including study quality, sample size, region, level of hospital, provincial economic condition, types of surgeries. A map for the distribution of *S. aureus* was drawn through MapInfo Professional 11.0 according to the subgroup analysis by provinces. We determined small sample size if at most 20 bacteria isolates or *S.aureus* isolates were included in analysis for primary studies respectively reporting the proportion of *S. aureus* or MRSA. Based on whether the annual Gross Domestic Product (GDP) per capita of each province in 2011 was higher or lower than the national average (35,181RMB) in China, provinces were categorized into higher or lower provincial economic condition \[[@pone.0116079.ref018]\].

Informal comparisons were made between subgroups for the proportions of *S. aureus* and MRSA by directly comparing the magnitudes of proportions between different subgroups instead of significance tests which tend to be misleading for the comparison in subgroup analysis. Statistical significance was defined as non-overlap of the confidence intervals of the proportions between the subgroups \[[@pone.0116079.ref019]\].

Meta-regression for the proportion of *S. aureus* isolates {#sec002k}
----------------------------------------------------------

Meta-regression was used to explore the impact of pre-defined factors on the proportion of *S. aureus* isolates. We defined logit(*P*) as the dependent variable where *P* referred to proportion of *S. aureus* isolates. All the independent factors were initially selected based on the expertise in clinical microbiology and the availability of related information in the included articles, including study quality, sample size, region, level of hospital, provincial economic condition and type of surgery, all of which were defined as dummy variables. The factors without colinearity indicated by no correlation to each other (P-value≥0.10) were finally included into the random-effects meta-regression model with restricted maximum likelihood (REML) method. The statistical significance of any single coefficient was tested by Z-test and 0.05 was used as the threshold of P-value for statistically significant difference.

Publication bias {#sec002l}
----------------

Egger's test served to assess the probability of publication bias for the overall *S. aureus* and MRSA proportion \[[@pone.0116079.ref020]\]. The test was based on the logit-transformed proportion and corresponding standard error. A P-value of less than 0.10 was regarded as statistical significance, indicating probable publication bias.

Results {#sec003}
=======

General information about included studies {#sec003a}
------------------------------------------

We retrieved 2904 references from six databases, of which 106 studies were eligible for inclusion ([Fig. 1](#pone.0116079.g001){ref-type="fig"}). All the studies, 105 published in Chinese and one in English, were hospital-based. [Table 1](#pone.0116079.t001){ref-type="table"}, [Table 2](#pone.0116079.t002){ref-type="table"} and [S3 Table](#pone.0116079.s006){ref-type="supplementary-material"} show detailed characteristics of included studies.

![Flow diagram of study inclusion.](pone.0116079.g001){#pone.0116079.g001}

10.1371/journal.pone.0116079.t001

###### General information of all the included studies.

![](pone.0116079.t001){#pone.0116079.t001g}

  **Study ID**                             **Province**   **Start**        **Finishing**    **Number of centers**   **Study type**    **Number of SSIs patients**   **Surgery type[\*](#t001fn001){ref-type="table-fn"}**   **Relevance to MRSA**   **Region**   **Hospital level**   **Economy**   **Score for risk of bias**
  ---------------------------------------- -------------- ---------------- ---------------- ----------------------- ----------------- ----------------------------- ------------------------------------------------------- ----------------------- ------------ -------------------- ------------- ----------------------------
  Ao 2007 \[[@pone.0116079.ref031]\]       Jiangxi        March 2005       March 2007       1                       Retrospective     89                            Orthopedic                                              No                      Urban        Tertiary             Lower         3
  Chang 2010 \[[@pone.0116079.ref032]\]    Shanxi         January 2007     December 2009    1                       Ambispective      95                            Multiple                                                No                      Urban        Tertiary             Lower         4
  Chen 2009a \[[@pone.0116079.ref033]\]    Fujian         January2006      December 2008    1                       Retrospective     Unclear                       Orthopedic                                              Yes                     Urban        Tertiary             Higher        2
  Chen 2009b \[[@pone.0116079.ref034]\]    Guangdong      January 2002     December 2006    1                       Prospective       Unclear                       Neurosurgery                                            No                      Urban        Tertiary             Higher        2
  Chen 2010 \[[@pone.0116079.ref035]\]     Beijing        January 2006     December 2008    1                       Retrospective     214                           Multiple                                                Yes                     Urban        Tertiary             Higher        3
  Chen 2012 \[[@pone.0116079.ref036]\]     Fujian         January 2007     December 2010    1                       Ambispective      105                           Multiple                                                No                      Rural        Non-tertiary         Higher        3
  Cui 2008 \[[@pone.0116079.ref037]\]      Henan          January 2007     December 2007    1                       Retrospective     1001                          Multiple                                                No                      Urban        Non-tertiary         Lower         2
  Dai 2012 \[[@pone.0116079.ref038]\]      Zhejiang       February 2009    May 2011         1                       Retrospective     50                            Abdominal                                               No                      Urban        Tertiary             Higher        3
  Deng 2010 \[[@pone.0116079.ref039]\]     Sichuan        Unclear          Unclear          10                      Cross-sectional   26                            Multiple                                                Yes                     Urban        Non-tertiary         Lower         3
  Ding 2010 \[[@pone.0116079.ref040]\]     Liaoning       January 2000     December 2009    1                       Retrospective     145                           Multiple                                                No                      Urban        Non-tertiary         Higher        3
  Dong 2007 \[[@pone.0116079.ref041]\]     Zhejiang       January 2006     December 2006    1                       Monitoring        Unclear                       Multiple                                                No                      Urban        Tertiary             Higher        3
  Duan 2008 \[[@pone.0116079.ref042]\]     Hubei          January 2002     December 2007    1                       Retrospective     18                            Multiple                                                Yes                     Rural        Non-tertiary         Lower         4
  Fan 2008 \[[@pone.0116079.ref043]\]      Hubei          January 2004     December 2007    1                       Retrospective     221                           Abdominal                                               Yes                     Urban        Tertiary             Lower         4
  Fan 2010 \[[@pone.0116079.ref044]\]      Zhejiang       January 2003     December 2008    1                       Retrospective     36                            Orthopedic                                              No                      Urban        Non-tertiary         Higher        2
  Gu 2009 \[[@pone.0116079.ref045]\]       Xinjiang       January 2002     December 2006    1                       Retrospective     76                            Gynecologic                                             No                      Urban        Non-tertiary         Lower         0
  Hao 2012 \[[@pone.0116079.ref046]\]      Hebei          October 2010     December 2011    1                       Unclear           61                            Orthopedic                                              Yes                     Urban        Tertiary             Lower         4
  He 2012 \[[@pone.0116079.ref047]\]       Jiangxi        January 2009     December 2011    1                       Monitoring        41                            Multiple                                                No                      Urban        Tertiary             Lower         5
  Huang 2012 \[[@pone.0116079.ref048]\]    Liaoning       June 2008        October 2010     1                       Retrospective     19                            Abdominal                                               No                      Urban        Non-tertiary         Higher        4
  Jiang 2009 \[[@pone.0116079.ref049]\]    Guangdong      January 2003     December 2007    1                       Retrospective     332                           Orthopedic                                              No                      Urban        Tertiary             Higher        2
  Jiang 2012 \[[@pone.0116079.ref050]\]    Beijing        January 2009     December 2010    1                       Monitoring        62                            Gynecologic                                             No                      Rural        Non-tertiary         Higher        6
  Li 2008 \[[@pone.0116079.ref051]\]       Henan          December 2004    December2007     1                       Retrospective     36                            Gynecologic                                             No                      Rural        Non-tertiary         Lower         2
  Li 2009a \[[@pone.0116079.ref052]\]      Sichuan        April 2008       August 2008      1                       Unclear           26                            Multiple                                                No                      Urban        Tertiary             Lower         3
  Li 2009b \[[@pone.0116079.ref053]\]      Liaoning       January 2006     December 2008    1                       Retrospective     15                            Gynecologic                                             No                      Urban        Non-tertiary         Higher        2
  Li 2009c \[[@pone.0116079.ref054]\]      Henan          January 2007     December 2008    1                       Retrospective     133                           Orthopedic                                              No                      Urban        Tertiary             Lower         4
  Li 2010a \[[@pone.0116079.ref055]\]      Hubei          January 2005     December 2008    1                       Retrospective     241                           Multiple                                                Yes                     Urban        Non-tertiary         Higher        3
  Li 2010b \[[@pone.0116079.ref056]\]      Hunan          January 2007     December 2009    Unclear                 Retrospective     106                           Multiple                                                No                      Rural        Non-tertiary         Lower         3
  Li 2010c \[[@pone.0116079.ref057]\]      Hebei          September 2007   September 2009   1                       Retrospective     139                           Orthopedic                                              Yes                     Urban        Tertiary             Lower         1
  Li 2011a \[[@pone.0116079.ref058]\]      Guangxi        January2007      June 2010        1                       Unclear           118                           Multiple                                                Yes                     Rural        Non-tertiary         Lower         4
  Li 2011b \[[@pone.0116079.ref059]\]      Jiangsu        Unclear          Unclear          Unclear                 Unclear           20                            Gynecologic                                             No                      Urban        Non-tertiary         Higher        2
  Li 2012 \[[@pone.0116079.ref060]\]       Xinjiang       November 2009    November 2011    1                       Retrospective     32                            Gynecologic                                             No                      Urban        Tertiary             Lower         4
  Lin 2007 \[[@pone.0116079.ref061]\]      Zhejiang       January 2004     June 2004        1                       Unclear           411                           Multiple                                                No                      Rural        Non-tertiary         Higher        3
  Lin 2008 \[[@pone.0116079.ref062]\]      Guangdong      January 2004     December 2007    1                       Ambispective      18                            Orthopedic                                              No                      Urban        Non-tertiary         Higher        4
  Lin 2009 \[[@pone.0116079.ref063]\]      Fujian         January 2007     December 2008    1                       Retrospective     31                            Abdominal                                               No                      Urban        Tertiary             Higher        3
  Ling 2011 \[[@pone.0116079.ref064]\]     Zhejiang       January 2007     December 2009    1                       Monitoring        224                           Orthopedic                                              Yes                     Urban        Non-tertiary         Higher        4
  Liu 2008 \[[@pone.0116079.ref065]\]      Guangdong      January 2005     May 2007         1                       Ambispective      113                           Abdominal                                               No                      Urban        Non-tertiary         Higher        4
  Liu 2010 \[[@pone.0116079.ref066]\]      Henan          January 2006     June 2009        1                       Ambispective      274                           Multiple                                                No                      Urban        Tertiary             Lower         4
  Liu 2011 \[[@pone.0116079.ref067]\]      Tianjin        January 2005     December 2008    1                       Ambispective      119                           Orthopedic                                              No                      Urban        Tertiary             Higher        3
  Liu 2012a \[[@pone.0116079.ref068]\]     Jiangxi        January 2010     February 2012    1                       Unclear           196                           Thoracic                                                Yes                     Urban        Tertiary             Lower         2
  Liu 2012b \[[@pone.0116079.ref069]\]     Henan          March 2010       March 2011       1                       Retrospective     128                           Abdominal                                               No                      Rural        Non-tertiary         Lower         3
  Liu 2012c \[[@pone.0116079.ref070]\]     Hubei          January 2008     December 2010    1                       Retrospective     213                           Multiple                                                Yes                     Rural        Non-tertiary         Lower         3
  Lv 2007 \[[@pone.0116079.ref071]\]       Zhejiang       January 2003     May 2006         1                       Retrospective     139                           Multiple                                                No                      Urban        Non-tertiary         Higher        4
  Lv 2012 \[[@pone.0116079.ref072]\]       Zhejiang       January 2006     June 2011        1                       Retrospective     26                            Abdominal                                               No                      Urban        Tertiary             Higher        3
  Mao 2011 \[[@pone.0116079.ref073]\]      Zhejiang       June 2008        September 2010   1                       Retrospective     285                           Orthopedic                                              Yes                     Urban        Tertiary             Higher        3
  Pang 2007 \[[@pone.0116079.ref074]\]     Sichuan        January 2001     December 2004    1                       Retrospective     64                            Multiple                                                No                      Rural        Non-tertiary         Lower         4
  Peng 2008 \[[@pone.0116079.ref075]\]     Hubei          January 2004     December 2007    1                       Unclear           78                            Multiple                                                Yes                     Rural        Non-tertiary         Lower         1
  Peng 2012a \[[@pone.0116079.ref076]\]    Hubei          January 2009     December 2010    1                       Retrospective     254                           Multiple                                                Yes                     Urban        Tertiary             Lower         3
  Peng 2012b \[[@pone.0116079.ref077]\]    Hubei          January 2008     May 2011         1                       Retrospective     169                           Multiple                                                Yes                     Urban        Tertiary             Lower         3
  Qian 2011 \[[@pone.0116079.ref078]\]     Zhejiang       January 2000     December 2009    1                       Retrospective     135                           Gynecologic                                             Yes                     Urban        Non-tertiary         Higher        3
  Qu 2008 \[[@pone.0116079.ref079]\]       Unclear        January 2006     December 2007    1                       Retrospective     75                            Multiple                                                Yes                     Unclear      Unclear              Unclear       3
  Qu 2011 \[[@pone.0116079.ref080]\]       Hubei          January 2006     January 2011     1                       Retrospective     113                           Multiple                                                No                      Rural        Non-tertiary         Lower         4
  Ren 2009 \[[@pone.0116079.ref081]\]      Ningxia        January 2007     August 2007      1                       Retrospective     23                            Multiple                                                Yes                     Rural        Non-tertiary         Lower         2
  Ruan 2011 \[[@pone.0116079.ref082]\]     Zhejiang       January 2007     December 2009    1                       Retrospective     67                            Abdominal                                               No                      Urban        Tertiary             Higher        4
  Sheng 2012 \[[@pone.0116079.ref083]\]    Zhejiang       January 2006     December 2011    1                       Retrospective     41                            Orthopedic                                              No                      Rural        Tertiary             Higher        2
  Shi 2011 \[[@pone.0116079.ref084]\]      Henan          January2006      December2009     1                       Prospective       325                           Multiple                                                Yes                     Urban        Tertiary             Lower         5
  Sun 2008 \[[@pone.0116079.ref085]\]      Shandong       March 2000       May 2005         1                       Unclear           29                            Ophthalmology                                           No                      Urban        Tertiary             Higher        2
  Sun 2012 \[[@pone.0116079.ref086]\]      Hubei          January 2009     December 2010    1                       Retrospective     221                           Multiple                                                Yes                     Urban        Tertiary             Lower         2
  Tang 2009 \[[@pone.0116079.ref087]\]     Hebei          January 2005     December 2005    Unclear                 Unclear           300                           Thoracic                                                No                      Urban        Tertiary             Lower         2
  Tang 2012 \[[@pone.0116079.ref088]\]     Guangdong      January 2008     December 2011    1                       Retrospective     65                            Unclear                                                 No                      Urban        Tertiary             Higher        3
  Tao 2011 \[[@pone.0116079.ref089]\]      Hubei          January 2007     December 2009    1                       Ambispective      20                            Neurosurgery                                            No                      Urban        Tertiary             Lower         3
  Tian 2011 \[[@pone.0116079.ref090]\]     Hubei          January 2008     December 2009    1                       Retrospective     Unclear                       Multiple                                                Yes                     Urban        Tertiary             Lower         3
  Wan 2009 \[[@pone.0116079.ref091]\]      Hunan          January 2005     December 2008    3                       Unclear           185                           Multiple                                                No                      Rural        Non-tertiary         Lower         3
  Wang 2007a \[[@pone.0116079.ref092]\]    Beijing        January 2001     December 2005    1                       Retrospective     48                            Abdominal                                               Yes                     Urban        Tertiary             Higher        2
  Wang 2007b \[[@pone.0116079.ref093]\]    Hubei          Unclear          Unclear          Unclear                 Unclear           Unclear                       Unclear                                                 Yes                     Urban        Tertiary             Lower         1
  Wang 2008 \[[@pone.0116079.ref094]\]     Hebei          January 2005     December 2007    1                       Unclear           Unclear                       Unclear                                                 No                      Urban        Tertiary             Lower         2
  Wang 2012 \[[@pone.0116079.ref095]\]     Zhejiang       June 2003        June 2011        1                       Retrospective     223                           Abdominal                                               No                      Urban        Tertiary             Higher        4
  Wei 2010 \[[@pone.0116079.ref096]\]      Guangdong      January 2008     December 2008    1                       Monitoring        53                            Gynecologic                                             No                      Urban        Tertiary             Higher        7
  Xiang 2012 \[[@pone.0116079.ref097]\]    Zhejiang       March 2008       September 2009   1                       Retrospective     47                            Orthopedic                                              No                      Rural        Non-tertiary         Higher        3
  Xie 2007 \[[@pone.0116079.ref098]\]      Zhejiang       January 2003     December 2005    1                       Prospective       211                           Multiple                                                Yes                     Urban        Tertiary             Higher        4
  Xie 2008 \[[@pone.0116079.ref099]\]      Hubei          January 2004     December 2006    1                       Retrospective     128                           Multiple                                                Yes                     Urban        Tertiary             Lower         4
  Xie 2010 \[[@pone.0116079.ref100]\]      Hubei          November 2007    November 2008    10                      Cross-sectional   80                            Multiple                                                No                      Urban        Tertiary             Lower         5
  Xie 2012 \[[@pone.0116079.ref101]\]      Sichuan        January 2005     October 2011     1                       Retrospective     426                           Unclear                                                 Yes                     Urban        Tertiary             Lower         2
  Xiu 2012 \[[@pone.0116079.ref102]\]      Heilongjiang   January 2011     December 2011    1                       Retrospective     29                            Multiple                                                No                      Urban        Tertiary             Lower         4
  Xu 2007 \[[@pone.0116079.ref103]\]       Beijing        August 1997      September 2006   1                       Retrospective     Unclear                       Neurosurgery                                            No                      Urban        Tertiary             Higher        2
  Xu 2010 \[[@pone.0116079.ref104]\]       Guangxi        Unclear          Unclear          Unclear                 Prospective       124                           Orthopedic                                              No                      Urban        Tertiary             Lower         4
  Xu 2011 \[[@pone.0116079.ref105]\]       Guangdong      November 2007    November 2010    1                       Retrospective     31                            Unclear                                                 No                      Urban        Non-tertiary         Higher        3
  Yan 2008 \[[@pone.0116079.ref106]\]      Guangdong      January 2003     September 2006   1                       Unclear           311                           Multiple                                                No                      Urban        Tertiary             Higher        4
  Yang 2009a \[[@pone.0116079.ref107]\]    Sichuan        January 2006     December 2007    1                       Retrospective     Unclear                       Multiple                                                No                      Rural        Non-tertiary         Lower         3
  Yang 2009b \[[@pone.0116079.ref108]\]    Sichuan        January 2007     December 2007    1                       Ambispective      46                            Unclear                                                 No                      Urban        Non-tertiary         Lower         4
  Yao 2011 \[[@pone.0116079.ref109]\]      Zhejiang       January 2005     December 2010    1                       Retrospective     51                            Abdominal                                               No                      Urban        Non-tertiary         Higher        4
  You 2011 \[[@pone.0116079.ref110]\]      Fujian         January 2001     June 2009        1                       Retrospective     50                            Thoracic                                                No                      Urban        Tertiary             Higher        3
  Yu 2012 \[[@pone.0116079.ref111]\]       Zhejiang       January 2009     July 2011        Unclear                 Retrospective     398                           Multiple                                                Yes                     Urban        Non-tertiary         Higher        3
  Yue 2009 \[[@pone.0116079.ref112]\]      Henan          June 2005        June 2008        1                       Retrospective     21                            Gynecologic                                             No                      Rural        Non-tertiary         Lower         3
  Zeng 2012 \[[@pone.0116079.ref113]\]     Hubei          January 2007     December 2010    Unclear                 Retrospective     108                           Gynecologic                                             Yes                     Rural        Non-tertiary         Lower         2
  Zhang 2007 \[[@pone.0116079.ref114]\]    Henan          January 2004     December 2005    1                       Unclear           91                            Orthopedic                                              No                      Urban        Tertiary             Lower         3
  Zhang 2008 \[[@pone.0116079.ref115]\]    Hubei          January 2004     December 2005    1                       Unclear           145                           Multiple                                                No                      Urban        Tertiary             Lower         2
  Zhang 2009a \[[@pone.0116079.ref116]\]   Sichuan        January 2009     June 2011        1                       Retrospective     142                           Unclear                                                 No                      Urban        Non-tertiary         Lower         3
  Zhang 2009b \[[@pone.0116079.ref117]\]   Hubei          January 2006     December 2008    1                       Retrospective     Unclear                       Multiple                                                Yes                     Urban        Tertiary             Lower         1
  Zhang 2010 \[[@pone.0116079.ref118]\]    Hunan          January 2008     December 2008    1                       Retrospective     47                            Abdominal                                               No                      Rural        Non-tertiary         Lower         4
  Zhang 2011a \[[@pone.0116079.ref119]\]   Sichuan        January 2006     December 2008    1                       Retrospective     160                           Multiple                                                No                      Urban        Non-tertiary         Lower         4
  Zhang 2011b \[[@pone.0116079.ref120]\]   Zhejiang       January 2007     December 2009    1                       Retrospective     87                            Abdominal                                               No                      Urban        Tertiary             Higher        2
  Zhang 2011c \[[@pone.0116079.ref121]\]   Hainan         March 2007       March 2009       1                       Retrospective     30                            Multiple                                                No                      Urban        Tertiary             Lower         3
  Zhang 2012 \[[@pone.0116079.ref122]\]    Gansu          January 2008     December 2009    Unclear                 Ambispective      252                           Multiple                                                Yes                     Urban        Tertiary             Lower         5
  Zhao 2011a \[[@pone.0116079.ref123]\]    Guizhou        January 2008     December 2010    1                       Retrospective     72                            Multiple                                                No                      Urban        Tertiary             Lower         3
  Zhao 2011b \[[@pone.0116079.ref124]\]    Shandong       January 2008     December 2010    1                       Retrospective     227                           Multiple                                                Yes                     Urban        Tertiary             Higher        4
  Zheng 2007 \[[@pone.0116079.ref125]\]    Zhejiang       January 2005     December 2005    1                       Retrospective     Unclear                       Urologic                                                Yes                     Urban        Tertiary             Higher        2
  Zheng 2011a \[[@pone.0116079.ref126]\]   Hubei          January 2008     December 2009    Unclear                 Unclear           148                           Unclear                                                 Yes                     Urban        Tertiary             Lower         4
  Zheng 2011b \[[@pone.0116079.ref127]\]   Hubei          January 2008     December 2009    1                       Retrospective     87                            Abdominal                                               Yes                     Urban        Non-tertiary         Lower         5
  Zheng 2011c \[[@pone.0116079.ref128]\]   Zhejiang       January 2005     December 2010    1                       Cross-sectional   41                            Multiple                                                No                      Urban        Tertiary             Higher        4
  Zhou 2007 \[[@pone.0116079.ref129]\]     Hainan         January 2001     December 2005    1                       Retrospective     38                            Gynecologic                                             No                      Urban        Tertiary             Lower         2
  Zhou 2008 \[[@pone.0116079.ref130]\]     Hainan         January 2001     December 2005    1                       Retrospective     18                            Gynecologic                                             No                      Urban        Non-tertiary         Lower         3
  Zhou 2011a \[[@pone.0116079.ref131]\]    Hubei          January 2005     December 2009    1                       Retrospective     1172                          Multiple                                                Yes                     Urban        Tertiary             Lower         5
  Zhou 2011b \[[@pone.0116079.ref132]\]    Beijing        October 2009     September 2011   1                       Prospective       24                            Thoracic                                                Yes                     Urban        Tertiary             Higher        3
  Zhu 2007 \[[@pone.0116079.ref133]\]      Hubei          January 2002     December 2006    1                       Retrospective     138                           Abdominal                                               No                      Urban        Tertiary             Lower         3
  Zhu 2008a \[[@pone.0116079.ref134]\]     Guizhou        January 2006     January 2008     1                       Retrospective     63                            Orthopedic                                              No                      Urban        Non-tertiary         Lower         4
  Zhu 2008b \[[@pone.0116079.ref135]\]     Jiangxi        January 2000     December 2006    1                       Retrospective     Unclear                       Multiple                                                Yes                     Urban        Tertiary             Lower         4
  Zhu 2010 \[[@pone.0116079.ref136]\]      Guangdong      December 2009    March 2010       1                       Unclear           20                            Gynecologic                                             No                      Urban        Tertiary             Higher        3

\* In this column multiple surgeries refer to the different kinds of surgeries involved in the study which cannot be discriminated or classified into a specific type of surgery.

10.1371/journal.pone.0116079.t002

###### Distribution of *S. aureus* and MRSA isolates in the included studies.
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  **Characteristics**                                  ***S. aureus***                               **MRSA**                               
  ---------------------------------------------------- --------------------------------------------- ---------- ------- -------- ---- ----- -------
  Publication year                                     2007                                          13         351     2,441    4    43    95
                                                       2008                                          16         380     1,636    6    84    198
                                                       2009                                          16         285     1,806    3    40    123
                                                       2010                                          14         200     1,257    4    42    92
                                                       2011                                          24         714     3,613    11   221   539
                                                       2012                                          23         582     2,855    10   194   455
  Surgery type                                         Orthopedic                                    16         362     2,022    5    35    143
                                                       Abdominal                                     15         161     1,163    3    35    64
                                                       Gynecologic                                   13         88      471      2    10    25
                                                       Thoracic                                      4          88      196      2    19    73
                                                       Others[\*](#t002fn001){ref-type="table-fn"}   49         1,556   8,754    23   445   1,003
                                                       Unclear                                       8          257     1,029    3    80    194
  Study design                                         Retrospective                                 67         1,794   10,169   26   520   1,204
                                                       Prospective                                   10         139     781      4    34    95
                                                       Ambispective                                  9          117     764      1    11    29
                                                       Cross-sectional                               3          38      133      1    1     2
                                                       Unclear                                       17         424     1,761    6    58    172
  Regions                                              Urban                                         85         2,111   11,603   31   563   1,344
                                                       Rural                                         20         378     1,925    6    55    135
                                                       Unclear                                       1          23      80       1    6     23
  Hospitals                                            Tertiary                                      63         1,740   9,581    25   499   1,168
                                                       Non-tertiary                                  42         749     3,947    12   119   311
                                                       Unclear                                       1          23      80       1    6     23
  Economic Condition                                   Higher                                        45         852     5,734    12   152   384
                                                       Lower                                         60         1,637   7,794    26   466   1,095
                                                       Unclear                                       1          23      80       1    6     23
  Study Quality                                        Higher                                        39         1,000   5,313    14   271   665
                                                       Lower                                         67         1,512   8,295    24   353   837
  Sample Size[\*\*](#t002fn002){ref-type="table-fn"}   \>20 isolates                                 95         2,464   13,435   26   561   1,392
                                                       ≤20 isolates                                  11         48      173      12   63    110
  Total                                                                                              106        2,512   13,608   38   624   1,502

\* Others refer to: 1) multiple surgeries involved in the study which cannot be classified into a specific type of surgery or 2) a specific type of surgery, rather than orthopedic, abdominal, gynecologic, or thoracic surgeries, which was reported in a small number of studies.

\*\* Sample size refers to isolates of all identified bacteria for the proportion of *S.aureus*, isolates of all identified *S.aureus* for the proportion of MRSA, and isolates of MRSA for the proportion of antibiotic resistance.

Methodological quality of studies {#sec003b}
---------------------------------

The methodological quality of studies was displayed in [Fig. 2](#pone.0116079.g002){ref-type="fig"} with more details in [S2 Table](#pone.0116079.s005){ref-type="supplementary-material"}, [S1 Fig](#pone.0116079.s001){ref-type="supplementary-material"} The maximum score that studies achieved was 7 while the minimum was 0. We finally identified 38 studies with relatively high quality which reached at least 4 scores in our quality assessment scale.

![Summary of risk of bias for all the included studies.](pone.0116079.g002){#pone.0116079.g002}

Overall proportions {#sec003c}
-------------------

106 studies, including a total of 13,608 isolates, reported proportions of *S. aureus* isolates. The pooled proportion of *S. aureus* isolates among patients with SSIs was 19.1% (95%CI 17.2--21.0%; I^2^ = 84.1%) ([Fig. 3](#pone.0116079.g003){ref-type="fig"}). The proportion was similar to 18.5% (1,452/7,848, 95%CI 17.7--19.4%) (Q = 0.32, df = 1, P-value = 0.570) in the US, but significantly exceeded the proportions of 12.7% (377/2,971, 95%CI 11.5--13.9%) (Q = 33.4, df = 1, P-value\<0.001) and 13.5% (515/3,812, 95%CI 12.5--14.6%) (Q = 28.3, df = 1, P-value\<0.001) reported through the China Nosocomial Infection Surveillance System.

![Overall proportion of *S. aureus* in patients with SSIs.](pone.0116079.g003){#pone.0116079.g003}

With respect to the proportion of MRSA, 1,502 isolates of *S. aureus* in 38 studies were included. The overall proportion of MRSA isolates was 41.3% (95%CI 36.5--46.3%; I^2^ = 64.6%) ([Fig. 4](#pone.0116079.g004){ref-type="fig"}). The proportion was significantly lower (Q = 10.3, df = 1, P-value = 0.001) than that of 53.9% in the US (150/278, 95%CI 48.1--59.7%).

![Overall proportion of MRSA in patients with *S. aureus* SSIs.](pone.0116079.g004){#pone.0116079.g004}

No evidence in Egger's test suggested publication bias for the overall proportion of *S. aureus* (t=-1.10, P-value = 0.275) and MRSA (t = 0.46, P-value = 0.651).

Subgroup analysis {#sec003d}
-----------------

All the results of subgroup analysis were summarized in [Table 3](#pone.0116079.t003){ref-type="table"} and the forest plots were presented in [S1 File](#pone.0116079.s002){ref-type="supplementary-material"}.

10.1371/journal.pone.0116079.t003

###### Summary of the pooled results of proportions of *S. aureus* and MRSA isolates.
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  **Subgroup**                                           **Proportions of *S. aureus* isolates**                    **Proportions of MRSA isolates**                                                                        
  ------------------------------------------------------ ---------------------------------------------------------- ---------------------------------- -------- ------ ------------ ------ ---- ------- ------ ------------ ------
  Surgery type                                           Orthopedic                                                 16                                 2,022    20.4   15.3--26.7   87.8   5    143     26.6   15.3--42.2   56.9
                                                         Abdominal                                                  15                                 1,281    13.8   10.3--18.4   70.0   3    64      55.0   21.4--84.5   74.1
                                                         Gynecologic                                                13                                 471      20.1   15.6--25.6   33.0   2    25      41.0   23.5--61.1   0
                                                         Thoracic                                                   4                                  196      41.1   26.3--57.7   74.4   2    73      39.1   3.8--91.2    94.0
                                                         Others[\*](#t003fn001){ref-type="table-fn"}                50                                 8,609    18.2   15.9--20.7   85.6   23   1,003   44.6   39.5--49.7   51.5
                                                         Unclear                                                    8                                  1,029    24.7   20.1--30.0   60.2   3    194     41.3   34.4--48.6   3.0
  Economic condition                                     Higher                                                     45                                 5,777    16.6   13.9--19.7   84.2   12   384     39.4   28.6--51.2   73.4
                                                         Lower                                                      60                                 7,751    20.7   18.5--23.2   81.8   25   1,095   42.8   37.5--48.3   59.4
                                                         Unclear                                                    1                                  80       28.8   19.9--39.6   \-     1    23      26.1   12.2--47.2   \-
  Region                                                 Urban                                                      85                                 11,678   18.5   16.4--20.7   85.8   31   1,344   41.5   36.3--46.9   66.5
                                                         Rural                                                      20                                 1,850    20.9   17.4--25.0   69.4   6    135     44.9   29.2--61.7   60.7
                                                         Unclear                                                    1                                  80       28.8   19.9--39.6   \-     1    23      26.1   12.2--47.2   \-
  Hospital Level                                         Tertiary                                                   63                                 9,613    18.3   15.9--21.0   88.2   25   1,168   42.7   36.9--48.7   69.1
                                                         Non-tertiary                                               42                                 3,915    20.0   17.5--22.6   68.8   12   311     39.0   30.0--48.7   52.2
                                                         Unclear                                                    1                                  80       28.8   19.9--39.6   \-     1    23      26.1   12.2--47.2   \-
  Quality                                                Higher                                                     39                                 5,225    17.9   15.5--20.6   78.5   14   665     40.1   32.6--48.0   65.6
                                                         Lower                                                      67                                 8,383    19.9   17.4--22.8   86.3   24   837     42.1   35.7--48.9   65.3
  Study Design                                           Retrospective                                              67                                 10,169   18.6   16.9--20.5   75.6   26   1,204   42.4   37.2--47.7   62.2
                                                         Non-retrospective[\*\*](#t003fn002){ref-type="table-fn"}   22                                 1,678    17.9   13.1--23.8   84.4   6    126     41.3   26.3--58.0   59.4
                                                         Unclear                                                    17                                 1,669    21.6   14.9--30.2   92.1   6    172     41.0   22.9--61.9   75.5
  Sample size[\*\*\*](#t003fn003){ref-type="table-fn"}   \>20 isolates                                              95                                 13,435   18.6   16.7--20.5   85.2   26   1,392   39.8   35.0--44.8   68.2
                                                         ≤20 isolates                                               11                                 173      28.1   19.8--38.1   38.7   12   110     53.6   36.1--70.3   53.1
  Start time                                             Before 2007                                                55                                 8,696    18.8   16.4--21.4   85.2   17   821     41.0   33.4--49.0   72.2
                                                         Since 2007                                                 47                                 4,642    19.0   16.1--22.3   83.2   19   638     42.3   35.6--49.2   60.1
                                                         Unclear                                                    4                                  270      25.5   20.6--31.1   0.1    2    43      32.6   20.3--47.8   0
  Total                                                                                                             106                                13,608   19.1   17.2--21.0   84.1   38   1,502   41.3   36.5--46.3   64.6

\* Others refer to: 1) multiple surgeries involved in the study which cannot be classified into a specific type of surgery or 2) a specific type of surgery, rather than orthopedic, abdominal, gynecologic, or thoracic surgeries, which was reported in a small number of studies.

\*\* Non-retrospective design comprises prospective, cross-sectional, ambispective study and surveillance.

\*\*\* Sample size in the proportions of *S. aureus* isolates refers to the number of all the detected bacteria isolates; in the proportions of MRSA it refers to the number of all *S. aureus* isolates.

The pooled proportion was 41.1% (95%CI 26.3--57.7%; I^2^ = 74.4%) for thoracic surgeries, 20.4% (95%CI 15.3--26.7%; I^2^ = 87.8%) for orthopedics surgeries, 20.1% (95%CI 26.3--57.7%; I^2^ = 74.4%) for gynecologic surgeries and 13.8% (95%CI 10.3--18.4%; I^2^ = 70.0%) for abdominal surgeries. In addition, *S. aureus* proportion was higher in studies conducted in low economic condition, rural or non-tertiary hospitals or with small sample size (at most 20 isolates of bacteria), although significant differences between subgroups were not found. On the other hand, the proportions seemed similar in studies with high and low quality, those with retrospective and non-retrospective design, or those beginning before and since 2007 (Fig. A-I in [S1 File](#pone.0116079.s002){ref-type="supplementary-material"}).

Geographical differences in *S. aureus* proportions by different provinces or municipalities across China were shown in [Fig. 5](#pone.0116079.g005){ref-type="fig"}. Among 21 areas the maximum point estimate of *S. aureus* proportion among all the provinces with available data was 33.3% (95%CI 15.8--57.1%) in Ningxia province, followed by Tianjin municipality (30.2%, 95%CI 21.9--40.1%) and Jiangxi province (30.0%, 95%CI 16.9--47.4%) and the minimum was 11.5% (95%CI 8.1--16.1%) in Gansu province. However, there was only one study available, respectively, for the proportion estimate in Ningxia, Jiangxi and Gansu.

![Province distribution of proportions of *S. aureus* isolates in China.](pone.0116079.g005){#pone.0116079.g005}

Regarding the pooled proportion of MRSA isolates (Fig. J-R in [S1 File](#pone.0116079.s002){ref-type="supplementary-material"}), the proportion was 55.0% (95%CI 21.4--84.5%, I^2^ = 74.1%) for abdominal surgeries, 41.0% (95%CI 23.5--61.1%, I^2^ = 0%) for gynecologic surgeries, 39.1% (95%CI 3.8--91.2%, I^2^ = 94.0%) for thoracic surgeries and 26.6% (95%CI 15.3--42.2%, I^2^ = 56.9%) for orthopedics surgeries. Furthermore, despite insignificant difference between subgroups, MRSA proportion tended to be higher in low economic condition, urban and tertiary hospitals as well as in studies with small sample size (at most 20 *S. aureus* isolates). Similar proportions can be found between studies with higher and lower quality, studies with retrospective and non-retrospective design, or studies with the start time of before 2007 and since 2007.

All the MRSA were sensitive to vancomycin (522/522) while only one isolate was resistant to linezolid (1/94). 79.9% (95%CI 67.4--88.4%; I^2^ = 0%) and 92.0% (95%CI 80.2--97.0%; I^2^ = 0%) of MRSA, respectively pooled from four and five studies, were resistant to clindamycin and erythromycin (Fig. S and Fig. T in [S1 File](#pone.0116079.s002){ref-type="supplementary-material"}).

Meta-regression for the proportion of *S. aureus* isolates {#sec003e}
----------------------------------------------------------

97 studies without any missing data were included for meta-regression to identify related potential factors for heterogeneity with statistical significance. As we found a significant correlation coefficient between levels of hospital and region (coefficient = 0.570, P-value\<0.001), provincial economic condition and region (coefficient=-0.198, P-value = 0.052), the region variable was therefore excluded out of the pre-defined independent factors for the meta-regression ([Table 4](#pone.0116079.t004){ref-type="table"}).

10.1371/journal.pone.0116079.t004

###### Summary results of meta-regression for the proportion of *S. aureus* isolates.
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  **Factor**           **Coefficient**   **SE**   **OR**   **95% CI (OR)**   **P-Value**           
  -------------------- ----------------- -------- -------- ----------------- ------------- ------- ---------
  Surgery type                                                                                     
                       Thoracic          \-       \-       1                 \-            \-      \-
                       Abdominal         -1.495   0.385    0.224             0.105         0.477   \<0.001
                       Gynecologic       -1.370   0.408    0.254             0.114         0.565   \<0.001
                       Orthopedic        1.043    0.369    0.352             0.171         0.726   0.005
                       Others            -1.281   0.351    0.278             0.140         0.552   \<0.001
  Economic condition                                                                               
                       Lower             \-       \-       1                 \-            \-      \-
                       Higher            -0.232   0.139    0.793             0.604         1.041   0.095
  Hospital level                                                                                   
                       Non-tertiary      \-       \-       1                 \-            \-      \-
                       Tertiary          -0.223   0.143    0.800             0.605         1.058   0.118
  Sample size                                                                                      
                       \<20 isolates     \-       \-       1                 \-            \-      \-
                       ≥20 isolates      -0.541   0.268    0.582             0.344         0.985   0.044
  Quality                                                                                          
                       Lower             \-       \-       1                 \-            \-      \-
                       Higher            -0.080   0.141    0.923             0.700         1.218   0.573
  Constant                               -0.513   0.443    \-                \-            \-      0.247

The meta-regression (residual I^2^ = 83.3%, adjusted R^2^ = 17.6%, P-value\<0.001 in the test for the goodness of model fit) showed that compared with thoracic, *S. aureus* proportion was significantly lower in abdominal (OR = 0.224, 95%CI 0.105--0.477, P-value\<0.001), gynecologic (OR = 0.254, 95%CI 0.114--0.565, P-value\<0.001) and orthopedic (OR = 0.352, 95%CI 0.171--0.726, P-value = 0.005) surgeries. Studies with relatively large sample size (\>20 isolates) were likely to conclude lower proportions of *S. aureus* (OR = 0.582, 95%CI 0.344--0.985, P-value = 0.044).

Discussion {#sec004}
==========

Proportions of *S. aureus* {#sec004a}
--------------------------

The overall proportion of *S. aureus* isolates (19.1%) was consistent with the reported proportion of 18.5% in the US in 2003 \[[@pone.0116079.ref021]\], but was significantly higher than both estimated in the China Nosocomial Infection Surveillance System (12.7% between 1999 and 2001, 13.5% between 1999 and 2005) \[[@pone.0116079.ref011], [@pone.0116079.ref012]\]. This difference between our review and the Chinese surveillance system could not be attributed to the change over time because of insignificant difference between the studies starting before 2007 and those starting after 2007 by subgroup analysis. However, the following reasons may result in such difference. First, the surveillance result derived from only 79 of 134 surveillance hospitals (58.9%), which may reduce the representativeness of the practical situation in China. Nevertheless, 106 studies in our review involved more than 125 hospitals distributed in 21 different provinces or municipalities, including tertiary and non-tertiary hospitals, urban and rural areas, which may be more representative of the real national status. Second, the sample size of bacteria isolates from the surveillance system (only 3,812 in total) was substantially less than that included in our review (13,608). Pooling data from 106 studies with a larger sample size may provide a more reliable estimate for national situation.

In addition, our finding can provide further useful information which was not available from the Chinese surveillance system, such as the stratified proportions by the surgery type, economics condition, hospital level and province. As shown in the subgroup analysis, *S. aureus* proportions varied between different surgery types---highest for thoracic surgeries (41.1%) whereas lowest for abdominal surgeries (13.8%). Meta-regression suggested the similar result that patients undergoing thoracic surgeries were much more vulnerable to SSIs by *S. aureus*, compared with patients with any other involved surgery type. This result was consistent with the guideline for prevention of SSIs, which concluded that *S. aureus* was the dominant pathogen causing SSIs following thoracic surgeries \[[@pone.0116079.ref008]\], indicating that *S. aureus* should be highly suspected in the case of SSIs after thoracic surgeries. On the contrary, with other influencing factors adjusted, patients with abdominal surgeries were less likely to suffer from SSIs by *S. aureus*. Priority may not be given to *S. aureus* in the SSIs after this surgery type because gram-negative bacilli, rather than *S. aureus*, tend to be predominant in the gastrointestinal tract usually involved in abdominal surgeries \[[@pone.0116079.ref022], [@pone.0116079.ref023]\]. Impoverished regions, non-tertiary hospitals, and some provinces or municipalities such as Ningxia, Tianjin and Jiangxi, may also require more attention paid to *S. aureus* SSIs.

Proportions of MRSA {#sec004b}
-------------------

Our estimate focused on SSIs and thus may close the gap of the surveillance system in China which merely reported the MRSA proportion of 79.9% (3,177/3,975) in all kinds of hospital infections instead of in SSIs \[[@pone.0116079.ref012]\]. Comparison between the results indicated that the proportion of MRSA in SSIs may be lower than the average level among a diversity of hospital infections. Besides, our review concluded a significantly lower proportion than that reported in a recent multi-center study with a smaller sample size in the US \[[@pone.0116079.ref024]\]. However, the status quo necessitates further improvement since MRSA accounted for more than 40% of *S. aureus* in our review.

Variation in the MRSA proportions was found between different surgery types: highest in abdominal surgeries (55.0%) and lowest in orthopedics surgeries (26.6%). While a recent study showed cases with MRSA SSIs accounted for 30.4% in those with *S. aureus* SSIs in the US \[[@pone.0116079.ref022]\], the high MRSA proportion (55.0%) following abdominal surgeries in our study provided an alarming picture that, despite *S. aureus* being subordinate pathogen in SSIs after abdominal surgeries, physicians still have to be highly cautious about MRSA in SSIs. On the contrary, orthopedic surgeries saw the lowest proportion of MRSA SSIs (26.6%) in spite of its high proportion of *S. aureus*. A study also concluded that the proportion of MRSA was the lowest in orthopedic surgeries among all the surgical procedures, although the proportion (31.9%) they calculated was higher than ours \[[@pone.0116079.ref010]\]. However, the mechanism seems still unclear and requires further studies to confirm.

Proportions of antibiotic-resistant MRSA {#sec004c}
----------------------------------------

Based on our findings, vancomycin and linezolid appeared to be still effective for treating MRSA in SSIs in vitro. Vancomycin therapy is the primary option in the case of limited current therapeutic methods for patients with MRSA infections \[[@pone.0116079.ref025]\]. In China, the surveillance system suggested that none of MRSA were resistant to vancomycin (0/3,102) between 1999 and 2005 in a variety of nosocomial infections including SSIs \[[@pone.0116079.ref012]\], which was similar to our result: we identified none of the MRSA isolates resistant to vancomycin (0/522) in SSIs. However, it is necessary to raise the awareness of the resistance of vancomycin since there has been evidence suggesting the observed rise in minimum inhibitory concentrations (MICs) of vancomycin from less than 0.5μg/mL in 2005 to 1.0 μg/mL in 2010 \[[@pone.0116079.ref026]\]. Linezolid is the first available oxazolidinone antibiotic, which uniquely inhibits bacterial protein synthesis by preventing formation of 70S initiation complex \[[@pone.0116079.ref027]\]. Although surveillance data on linezolid was absent, one of 94 MRSA isolates in our findings was resistant to linezolid. But currently no robust clinical evidence can demonstrate whether linezolid or vancomycin is superior in the treatment of MRSA SSIs \[[@pone.0116079.ref028]\]. Continuous surveillance of drug resistance for both antibiotics in this treatment is necessary and crucial for the clinical practice.

On the other hand, clindamycin and erythromycin, inhibiting protein synthesis by their effect on ribosome function and commonly used in clinical practice for MRSA SSIs \[[@pone.0116079.ref027], [@pone.0116079.ref029]\], may have a doubtful effectiveness. The proportion of MRSA resistant to clindamycin in our findings (79.9%) was also similarly suggested in the surveillance system for nosocomial infections---78.9% (1,137/1,445) \[[@pone.0116079.ref012]\]. In our review, more than 90.0% MRSA isolates were identified to be resistant to erythromycin, far higher than that in the UK bacteraemia surveillance where erythromycin resistance only occurred in 67% of MRSA \[[@pone.0116079.ref030]\]. As such, both treatments may not be the first choice when MRSA in SSIs is suspected.

Limitations {#sec004d}
-----------

There are several limitations in this review. First, methodological quality of the included studies is the main concern for the combined estimates because less than half of the studies are of high quality according to our criteria. However, study quality seems not to be the main heterogeneity source as both subgroup analysis and meta-regression showed that the pooled result from studies of higher quality were consistent with that from those of lower quality. Second, we only included studies published after 2007 so as to understand the current proportion of *S. aureus* and MRSA in SSIs. Considering some studies had started before 2007, we conducted subgroup analysis for studies initiating before and after 2007 to ensure that it was reasonable to combine results from all included studies to provide more precise estimates and facilitate the meta-regression. Third, none of the pre-defined variables can fully explain the variance in proportions of *S. aureus* (I^2^ = 84.1%) and MRSA (I^2^ = 64.6%) in subgroup analysis and meta-regression, which could result in uncertainty around the pooled proportions. The major obstacle of extensively exploring the potential source of variation is the limited information about the heterogeneity reported in the publication, such as the duration of surveillance, MICs and molecular epidemiology, which may be significantly associated with the heterogeneity but cannot be examined in our review. However, meta-regression did find that some factors with available information, such as the types of surgery and sample sizes, may partly contribute to the heterogeneity across studies. In addition, despite informal comparisons between subgroups by 95%CI rather than the significance test, the problem with multiple comparisons may be raised in the comparisons with no adjustment made with a stricter criterion for the significant difference. Further study may also be required to confirm some pooled results derived from limited number of included studies in our review.

Conclusion {#sec005}
==========

In conclusion, the overall proportion of *S. aureus* causing SSIs in mainland China was similar to that in the US, and the proportion of MRSA was possibly lower. The real proportion of *S. aureus* may be higher than that reported from the Chinese surveillance system. Both proportions of *S. aureus* and MRSA tended to depend on types of surgeries. Therefore, clinicians should take into account the types of surgery when taking care of post-operative patients and managing *S. aureus* and MRSA SSIs. Vancomycin and linezolid appeared to be effective for MRSA in SSIs. Further well-designed studies on this topic, including surveillance and primary prospective studies, are required to provide further reliable evidence.
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